MELISSA FRAZIER: Open Payments
NPI 1184886293 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 60 payments from 27 companies in 2025. Trend: 2023 $553 · 2024 $481 · 2025 $1,318
Food & beverage: $1,219Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $199 |
| Exelixis Inc. | 4 | $150 |
| E.R. Squibb & Sons, L.L.C. | 6 | $104 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 5 | $88 |
| PFIZER INC. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| BeOne Medicines USA, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $54 |
| Janssen Biotech, Inc. | 2 | $47 |
Products named: IMFINZI, OPDIVO, KEYTRUDA, CALQUENCE, INGREZZA, CABOMETYX, KISQALI, BRUKINSA.
Industry payments across AL — which companies pay providers there.
